Literature DB >> 6266631

Isolation and growth characteristics of continuous cell lines from small-cell carcinoma of the lung.

O S Pettengill, G D Sorenson, D H Wurster-Hill, T J Curphey, W W Noll, C C Cate, L H Maurer.   

Abstract

Sixteen continuous tumor-cell cultures have been isolated from 91 tissue specimens from patients with small-cell carcinoma of the lung. Biopsy and autopsy specimens of primary and metastatic tumors have been utilized. The developing cell lines were recognized by proliferation of tumor cells in the culture from one to 14 weeks after explanation and have been maintained for up to four years. Primary lung tumor, bone marrow aspirations, pleural effusions and other metastases have all been productive explant material for the development of cell lines. Their human origin has been demonstrated by chromosome and/or isoenzyme analysis. Dense core vesicles, characteristically found in small-cell tumor cells were observed by electron microscopic examination of cultured cells. Growth rates in vitro have been measured and the in vitro cycle time in tumors of one cell line (DMS 79) has been compared with in vivo cycle time in tumors arising from DMS 79 cells in nude athymic mice.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6266631     DOI: 10.1002/1097-0142(19800301)45:5<906::aid-cncr2820450513>3.0.co;2-h

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  55 in total

1.  Selection of anti-SCLC antibodies for diagnosis of bone marrow metastasis.

Authors:  A T Myklebust; K Beiske; A Pharo; C D Davies; S Aamdal; O Fodstad
Journal:  Br J Cancer Suppl       Date:  1991-06

2.  Differential utilization of calcitonin gene regulatory DNA sequences in cultured lines of medullary thyroid carcinoma and small-cell lung carcinoma.

Authors:  A de Bustros; R Y Lee; D Compton; T Y Tsong; S B Baylin; B D Nelkin
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

3.  Loss of the retinoblastoma protein-related p130 protein in small cell lung carcinoma.

Authors:  K Helin; K Holm; A Niebuhr; H Eiberg; N Tommerup; S Hougaard; H S Poulsen; M Spang-Thomsen; P Norgaard
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

4.  Human monoclonal antibodies to sialyl-Lewis (CA19.9) with potent CDC, ADCC, and antitumor activity.

Authors:  Ritsuko Sawada; Shu-Man Sun; Xiaohong Wu; Feng Hong; Govind Ragupathi; Philip O Livingston; Wolfgang W Scholz
Journal:  Clin Cancer Res       Date:  2011-02-22       Impact factor: 12.531

Review 5.  Studying lung cancer in the laboratory: 1--Development of model systems.

Authors:  R J Fergusson; J F Smyth
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

6.  Differential expression of intermediate filament proteins distinguishes classic from variant small-cell lung cancer cell lines.

Authors:  J L Broers; D N Carney; L de Ley; G P Vooijs; F C Ramaekers
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

7.  Tetanus toxin as a marker for small-cell lung cancer cell lines.

Authors:  J Heymanns; K Neumann; K Havemann
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

8.  Expression of vitamin D receptor in lung cancer.

Authors:  U Kaiser; M Schilli; B Wegmann; P Barth; S Wedel; J Hofmann; K Havemann
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

9.  Capsaicin displays anti-proliferative activity against human small cell lung cancer in cell culture and nude mice models via the E2F pathway.

Authors:  Kathleen C Brown; Ted R Witte; W Elaine Hardman; Haitao Luo; Yi C Chen; A Betts Carpenter; Jamie K Lau; Piyali Dasgupta
Journal:  PLoS One       Date:  2010-04-20       Impact factor: 3.240

10.  Establishment and characterization of a continuous murine uterine cervix cancer cell line metastatic to lymph nodes and lungs.

Authors:  S S Qian; J Gao; J X Wang; Y Y Cai; Y Liu; B G Li; H Y Dong; G De Bruyne; M Mareel
Journal:  In Vitro Cell Dev Biol       Date:  1987-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.